This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Auxilium Pharmaceuticals Inc (AUXL)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 47.75M 35.86M 37.54M 128.21M
Receivables 96.46M 57.54M 45.14M 33.53M
Inventories 42.50M 22.13M 53.10M 38.80M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 238.59M 240.87M 255.14M 202.91M
Property, Plant & Equipment, Gross 65.78M 60.05M 51.29M 44.65M
Accumulated Depreciation & Depletion 30.51M 30.83M 21.67M 14.71M
Property, Plant & Equipment, Net 35.27M 29.22M 29.62M 29.94M
Intangibles 749.45M 0.00 0.00 0.00
Other Non-Current Assets 73.72M 57.30M 16.20M 11.06M
Total Non-Current Assets 962.58M 86.52M 45.83M 40.99M
Liabilities & Shareholder Equity
Total Assets 1.20B 327.39M 300.97M 243.90M
Accounts Payable 940.00K 3.56M 4.48M 5.08M
Short Term Debt 13.61M 0.00 0.00 0.00
Other Current Liabilities 57.93M 0.00 1.15M 988.00K
Total Current Liabilities 196.50M 97.08M 91.07M 64.17M
Long Term Debt 535.28M 0.00 0.00 0.00
Deferred Income Taxes 23.82M 4.14M 5.38M 6.40M
Other Non-Current Liabilities 194.11M 26.29M 120.12M 78.89M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 753.21M 30.43M 125.50M 85.29M
Total Liabilities 949.71M 127.50M 216.57M 149.46M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 251.46M 199.89M 84.40M 94.44M
Common Par 497.00K 494.00K 482.00K 479.00K
Additional Paid In Capital 594.97M 525.35M 495.95M 472.66M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -340.18M -322.12M -408.06M -375.14M
Treasury Stock -3.49M -3.34M -3.24M -3.06M
Other Equity Adjustments -332.00K -508.00K -735.00K -493.00K
Total Capitalization 786.75M 199.89M 84.40M 94.44M
Total Equity 251.46M 199.89M 84.40M 94.44M
Total Liabilities & Stock Equity 1.20B 327.39M 300.97M 243.90M
Total Common Shares Outstanding 49.60M 49.28M 48.10M 47.78M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 145.06K 136.40K 131.59K 123.54K
Basic Weighted Shares Outstanding 49.34M 48.77M 47.89M 47.43M
Diluted Weighted Shares Outstanding 49.34M 49.28M 47.89M 47.43M
Number of Employees 639 526 530 565
Number of Part-Time Employees 0 0 0 0

AUXL Auxilium Pharmaceuticals Inc

Analysts Ratings for AUXL

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 8 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

AUXL Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs